BiBB receives another Intention to Grant notice for EndoDrill in Europe
Today, the cancer diagnostics company BiBBInstruments AB ("BiBB” or the "Company") announces that the Company has received an additional Intention to Grant from the European Patent Office (“EPO”). The announcement means that the EPO intends to approve the Company's first patent family in Europe for EndoDrill[®], the world's first CE-marked electric-driven endoscopic biopsy instrument. This is the second Intention to Grant notice from the EPO in Q1 2023 relating to the EndoDrill[®] patent portfolio and includes important characteristics of the method. A few formal steps will follow before a